Literature DB >> 9136844

Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis.

P Di Sebastiano1, T Fink, E Weihe, H Friess, P Innocenti, H G Beger, M W Büchler.   

Abstract

BACKGROUND & AIMS: Changes in innervation pattern and neuropeptide content have been shown in chronic pancreatitis (CP), including increased neuronal expression of growth-associated protein 43 (GAP-43). We used GAP-43 as an established marker of neuronal plasticity and correlated histological findings with pain scores of patients with CP.
METHODS: In tissue samples from 29 patients with CP, the parenchyma-fibrosis ratio, degree of perineural immune cell infiltration, and neuronal GAP-43 immunoreactivity were determined by digitized morphometry and correlated with individual pain scores.
RESULTS: In CP, GAP-43 was significantly increased in pancreatic nerve fibers and intrinsic neurons. GAP-43 expression correlated with individual pain scores. The infiltration of pancreatic nerves by immune cells was significantly correlated with the intensity of pain. Pain scores correlated neither with the degree of pancreatic fibrosis nor with the duration of the disease.
CONCLUSIONS: The results suggest that infiltration of pancreatic nerves by immune cells and neuronal plasticity are pathogenic factors for the generation of pain, whereas the degree of pancreatic fibrosis has no major impact on pain in CP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9136844     DOI: 10.1016/s0016-5085(97)70047-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  Unravelling the mystery of pancreatic pain.

Authors:  C F Frey; W Ellis
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

2.  Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist.

Authors:  Qingmin Chen; Louis P Vera-Portocarrero; Michael H Ossipov; Marina Vardanyan; Josephine Lai; Frank Porreca
Journal:  Pancreas       Date:  2010-11       Impact factor: 3.327

Review 3.  Pathogenesis of pain in chronic pancreatitis: ongoing enigma.

Authors:  Philippus C Bornman; Israel N Marks; Andrew W Girdwood; Pascal O Berberat; Antanas Gulbinas; Markus W Büchler
Journal:  World J Surg       Date:  2003-10-27       Impact factor: 3.352

Review 4.  Chronic pancreatitis: the perspective of pain generation by neuroimmune interaction.

Authors:  P Di Sebastiano; F F di Mola; D E Bockman; H Friess; M W Büchler
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

5.  Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations.

Authors:  Louis P Vera-Portocarrero; Ying Lu; Karin N Westlund
Journal:  Anesthesiology       Date:  2003-02       Impact factor: 7.892

Review 6.  Current understanding of the neuropathophysiology of pain in chronic pancreatitis.

Authors:  Amporn Atsawarungruangkit; Supot Pongprasobchai
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

7.  The Beger procedure--duodenum-preserving pancreatic head resection.

Authors:  Hans G Beger; Rainer Kunz; Bertram Poch
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

8.  Brain-derived neurotrophic factor is upregulated in rats with chronic pancreatitis and mediates pain behavior.

Authors:  Michael S Hughes; Mohan Shenoy; Liansheng Liu; Tugba Colak; Kshama Mehta; Pankaj J Pasricha
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

9.  Substance P and calcitonin gene related peptide mediate pain in chronic pancreatitis and their expression is driven by nerve growth factor.

Authors:  LianSheng Liu; Mohan Shenoy; Pankaj Jay Pasricha
Journal:  JOP       Date:  2011-07-08

10.  Effects of sensory denervation by neonatal capsaicin administration on experimental pancreatitis induced by dibutyltin dichloride.

Authors:  Tsukasa Ikeura; Yosky Kataoka; Taketoshi Wakabayashi; Tetsuji Mori; Yasuharu Takamori; Shoichiroh Takamido; Kazuichi Okazaki; Hisao Yamada
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.